Clinical Trial Report definition

Clinical Trial Report means, with respect to a human clinical study of a Product, the final study report from such clinical study.
View Source
Clinical Trial Report means a written description of a clinical
View Source
Clinical Trial Report means a report of a clinical study of any Lead Molecule or Product where the clinical and statistical description, presentations, and analyses are integrated into a single report, incorporating tables and figures into the main text of the report or at the end of the text, with appendices containing such information as the protocol, sample case report forms, investigator-related information, information related to the test drugs/investigational products including active control/comparators, technical statistical documentation, related publications, patient data listings, and technical statistical details such as derivations, computations, analyses, and computer output.
View Source

Examples of Clinical Trial Report in a sentence

  • In addition, with respect to each Phase II Clinical Trial completed for any Product during the ROFN Period, as promptly as practicable following completion of such Clinical Trial, RBNC shall prepare and deliver to Amgen the Clinical Trial Report with respect to such Phase II Clinical Trial.

  • UHN and/or UHN CRO shall provide such Monthly Clinical Trial Report to Avro within [***] after the end of each calendar month.

  • The Parties shall work together to ensure such Monthly Clinical Trial Report is in a form acceptable to Avro.

  • OV shall provide R-Pharm with (a) an electronic draft of the final clinical study report and the tables and listings (“mBC Clinical Trial Report”) for R-Pharm to provide comments to OV (which comments shall be provided within forty-five (45) days of receipt of the draft of the mBC Clinical Trial Report) and (b) a final version of the mBC Clinical Trial Report, in each case as soon as reasonably practicable following mBC Clinical Trial Completion.

  • OV shall consider in good faith any comments provided by R-Pharm on the mBC Clinical Trial Report and shall not include any statements relating to the Product which have not been approved by R-Pharm.

  • At the conclusion by Connetics of its pivotal clinical trial in the U.S. for Relaxin ("Pivotal Clinical Trial"), Connetics shall use its Best Efforts to promptly provide Suntory with a draft report of the data from such Pivotal Clinical Trial, and promptly provide Suntory with the final report of such Pivotal Clinical Trial ("Pivotal Clinical Trial Report").

  • The final payment will be due on delivery of the final Clinical Trial Report and publishable manuscript provided for in clause 2(g), in each case, as more fully described in the Financial Support Schedule attached hereto as Appendix B.

  • Within 12 months of contract award or sooner if it becomes available, provide an Interim Clinical Trial Report that includes data summary and analysis, interpretation, and conclusions for the dose-response study.

  • Clinical Trial Report The report will be based on an electronic template provided by Prana, or prepared in Microsoft WORD in a format compliant with ICH guidelines.

  • Covance will be responsible for the final statistical analysis and the Clinical Trial Report.